Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

  • There is currently no data for INDV

Indivior appoints Mark Crossley as CEO

Mon, 29th Jun 2020 07:44
(Sharecast News) - Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.
Crossley, who has been chief financial and operations officer at Indivior since February 2017, was chief strategy officer from 2014 to 2017 and served as finance director, leading the demerger of Indivior from its former parent.

Prior to joining the company in 2012, he spent 13 years at Procter & Gamble in various finance leadership positions and eight years as an officer in the United States Coast Guard.

Shaun Thaxter is stepping down stepping down by mutual agreement with the board.

Meanwhile, Ryan Preblick, currently senior vice president of Global Financial Planning and Analysis Commercial Operations, has been appointed interim CFO.

Indivior, which makes opioid addiction treatment product Suboxone Film, said it will initiate a search for a permanent CFO and will assess whether to appoint a separate operations officer.

Crossley said: "There remains a very significant opportunity for Indivior in the years ahead, and I look forward to working with the board to deliver the full potential of our key assets, to resolve outstanding investigations and litigations as expeditiously as possible, and to ensure that we continue to play a leading role in helping patients, doctors, and communities fight the human crisis of opioid addiction."

Related News

IN BRIEF: Indivior shares de-listed from London as focuses on US
25 Jul 2025

IN BRIEF: Indivior shares de-listed from London as focuses on US

Indivior PLC - Richmond, Virginia-based pharmaceutical maker focused on treating opioid addiction - Indivior shares are cancelled from trading in Lond...

London close: Stocks slip on slew of UK data
30 Jun 2025

London close: Stocks slip on slew of UK data

(Sharecast News) - London stocks ended lower on Monday as investors digested a series of UK economic data and monitored developments in North American...

Indivior News

IN BRIEF: Indivior shares de-listed from London as focuses on US
25 Jul 2025

IN BRIEF: Indivior shares de-listed from London as focuses on US

Indivior PLC - Richmond, Virginia-based pharmaceutical maker focused on treating opioid addiction - Indivior shares are cancelled from trading in Lond...

London close: Stocks slip on slew of UK data
30 Jun 2025

London close: Stocks slip on slew of UK data

(Sharecast News) - London stocks ended lower on Monday as investors digested a series of UK economic data and monitored developments in North American...

LONDON MARKET MIDDAY: Stocks mixed with high demand for defence firms
2 Jun 2025

LONDON MARKET MIDDAY: Stocks mixed with high demand for defence firms

(Alliance News) - Stock prices in London were mixed at midday on Monday, as uncertainty persists in the UK manufacturing sector.

Indivior to leave London Stock Exchange in July to focus on US listing
2 Jun 2025

Indivior to leave London Stock Exchange in July to focus on US listing

(Alliance News) - Drug maker Indivior PLC will withdraw its shares from trading on the London Stock Exchange in July, the company confirmed on Monday,...

Indivior to cancel secondary listing in London
2 Jun 2025

Indivior to cancel secondary listing in London

(Sharecast News) - Drugmaker Indivior has announced plans to cancel its secondary listing in London, just a year after moving its primary listing to t...

EARNINGS: Tracsis loss widens but lifts dividend, announces buyback
24 Apr 2025

EARNINGS: Tracsis loss widens but lifts dividend, announces buyback

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...